Chugai Pharmaceuticals has promoted Ruth Currie to managing director of its UK business.
Currie takes over from John Halls, who also receives a promotion that sees him become managing director for Chugai’s commercial activities across Europe.
In her new role, Currie will oversee all UK commercial operations of Chugai, which has been a subsidiary of Roche since 2002. She will also join Chugai’s European leadership team.
Currie has been with Chugai, the original developers of RoAcemtra, since 2009, holding several senior positions, including most recently as UK sales director.